Physician profile
Arshad K Rahim
NPI 1225151665
$35,270.94
in general payments reported to CMS, 2019-2025
5 companies · $9,900 in 2025
The $9,900 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,655 · 2020: $6,206 · 2021: $4,800 · 2022: $3,010 · 2024: $5,700 · 2025: $9,900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21,255.44 | 2019-2025 | |
| Paratek Pharmaceuticals, INC. | $4,800.00 | 2021 | |
| Sanofi Pasteur INC. | $3,773.50 | 2020 | |
| Dexcom, INC. | $3,010.00 | 2022 | |
| Tersera Therapeutics LLC | $2,432.00 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arshad Rahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.